The interaction of CD44, a cell surface adhesion receptor, and matrix metalloproteinase 9 (MMP9) results in secretion of active MMP9 leading to migration and invasion of prostate cancer cells26. This evidence concerns the gene MMP9 and prostate carcinoma.